Patient's barrier to initiate insulin therapy for type 2 D.M
- PMID: 39400863
- DOI: 10.1007/s11845-024-03826-y
Patient's barrier to initiate insulin therapy for type 2 D.M
Abstract
Background: Diabetes Mellitus is a health challenging of the century, more than 300 million people lives with diabetes, and it is one of the biggest global health concerns, awing to its complications. Good glycemic control is the cornerstone to decrease risk of type 2 diabetes complications. Even though, many people still have poor glycemic control which can be partly attributed to late insulin initiation, that can be challenging and forced by numbers of barriers. Identification and analysis of these barriers is crucial to find out effective way to overcome them.
Aim: To assess patient's barriers to initiate insulin therapy among diabetic patients.
Method: A case series study was conducted during the period extending from July 2023 to June 2024, and a total of 360 participants with type two diabetes were included in this study from four Family Medicine Health Centers. Collected data tabulated and analyzed using Excel sheets and applying the Statistical Package for the Social Sciences (SPSS) Version 24.
Results: 26% of the participants were 45-55 years age group, 40% has been diagnosed with diabetes for 5-10 years, and 66% have developed diabetic complications. Fear from hypoglycemia was the comments barrier to initiate insulin therapy and is seen in 84% of the participants.
Conclusion: Many barriers have been identified to influence the initiation of insulin therapy, fear from hypoglycemia was found to be the most influencing barrier. Increasing patient's awareness of symptoms of hypoglycemia, and always take their meal after insulin injection can help to overcome hypoglycemia.
Keywords: Barrier; Hypoglycemia; Insulin; Type 2 diabetes.
© 2024. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
Conflict of interest statement
Declarations. Ethical consideration: Ethical approval of the study has been obtained from scientific and ethical committee of College of Medicine. Signed consent was obtained from all participants prior their registration. Financial interest: The authors declare they have no any financial interests. Consent for publication: The researchers declare that there is no any conflict of interest. Conflict of interest: No conflict of interests was declared by the authors.
Similar articles
-
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study.Adv Ther. 2024 May;41(5):1967-1982. doi: 10.1007/s12325-024-02830-z. Epub 2024 Mar 21. Adv Ther. 2024. PMID: 38512540 Free PMC article.
-
Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?Diabetes Technol Ther. 2011 Feb;13(2):93-8. doi: 10.1089/dia.2010.0192. Diabetes Technol Ther. 2011. PMID: 21284474
-
Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.Clin Ther. 2007;29 Spec No:1236-53. Clin Ther. 2007. PMID: 18046925 Review.
-
Psychological insulin resistance in geriatric patients with diabetes mellitus.Patient Educ Couns. 2014 Mar;94(3):417-22. doi: 10.1016/j.pec.2013.11.010. Epub 2013 Dec 1. Patient Educ Couns. 2014. PMID: 24341962
-
Minimizing the risk of hypoglycemia in older adults: a focus on long-term care.Consult Pharm. 2009 Jun;24 Suppl B:18-24. Consult Pharm. 2009. PMID: 19555132 Review.
Cited by
-
Correlation Analysis of Hypoglycemic Fear and Psychological Well-Being and Family Support Function in Older Adults Diabetic Patients.Diabetes Metab Syndr Obes. 2024 Nov 27;17:4501-4509. doi: 10.2147/DMSO.S486509. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 39640925 Free PMC article.
References
-
- Haque M, Emerson SH, Dennison CR et al (2005) Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. S Afr Med J 95(10):798–802 - PubMed
-
- Hussein A, Mostafa A, Areej A et al (2019) The perceived barriers to insulin therapy among type 2 diabetic patients. Afr Health Sci 19(1):1638–1646. https://doi.org/10.4314/ahs.v19i1.39 - DOI - PubMed - PMC
-
- Rajab A, Khaloo P, Rabizadeh S et al (2020) Barriers to initiation of insulin therapy in poorly controlled type 2 diabetes based on self-determination theory. East Mediterr Health J 26(11):1331–1338. https://doi.org/10.26719/emhj.20.027 - DOI - PubMed
-
- Al-Sofiani ME, Batais MA, Aldhafiri E, Alzaid A (2021) Pharmacological treatment of type 2 diabetes in Saudi Arabia: A consensus statement from the Saudi Society of Endocrinology and Metabolism (SSEM). Diabetes Metab Syndr 15(3):891–899. https://doi.org/10.1016/j.dsx.2021.04.003 - DOI - PubMed
-
- Russell-Jones D, Pouwer F, Khunti K (2018) Identification of barriers to insulin therapy and approaches to overcoming them. Diabetes Obes Metab 20(3):488–496. https://doi.org/10.1111/dom.13132 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical